Home
Resources
Publications
The Anxiolytic Effects of a Valerian Extract Is Based on Valerenic Acid

The Anxiolytic Effects of a Valerian Extract Is Based on Valerenic Acid

Axel Becker, Falko Felgentreff, Helmut Schröder, Beat Meier, Axel Brattström

BMC Complement Altern Med. 2014 Jul 28;14:267.

PMID: 25066015

Abstract:

Background:
Valerian is commonly used for the treatment of insomnia and anxiety. Valerian extracts allosterically modulate GABA-A receptors and induced an anxiolytic activity. This activity is closely related to valerenic acid. In the present experiments it was investigated whether acetoxy valerenic acid may interfere with the anxiolytic action of valerenic acid.
Methods:
Situational anxiety was measured using male CD-1 mice in the elevated plus maze test after oral administration of the test substances. In addition the body core temperature was measured. For the 3H-GABA binding assay dissected tissue from frontal cortex of male RjHan:WI rats were used. Statistical evaluation was performed by means of the non-parametric Kruskal-Wallies H-test, followed by the two-tailed Mann-Whitney U-test.
Results:
Adding of acetoxy valerenic acid abolished the anxiolytic action of valerenic acid. There was no effect on body core temperature. Moreover, the valerian extract did not show any affinity to benzodiazepine binding sites.
Conclusion:
The determining compound for the observed anxiolytic effect of the valerian extract is its content of valerenic acid.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP3569106	Valerenic acid		3569-10-6	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: